Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 180 composition records across product categories including Home maintenance, Cleaning and safety, Raw materials.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of HYDROXYPROPYL CELLULOSE (1600000 WAMW) in our catalog (epa_cpdat).
Products
180
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 180 composition records across product categories including Home maintenance, Cleaning and safety, Raw materials. EPA CPDat classifies this chemical for functional uses including Filler, Film former, Emulsifier.
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 139 mg
US
FDA
Vitamin C + Amla Extract 1000mg + Zinc
Carbamide Forte
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 375 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 1249 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 613 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 1050 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 528 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 356 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 92 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 90 mg
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Maximum daily exposure: 6 mg
US
FDA
Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 87 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 41.4 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 150 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 204 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 13 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 194 mg
US
FDA
Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 500 mg
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 244 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 200 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 230 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 10 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 13.6 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 450 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 864 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 131.67 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 187.6 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 4 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Potency: 39.2 mg
US
FDA
Route: TOPICAL; Dosage form: GEL; Maximum daily exposure: 222 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 6 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Potency: 0.2 %w/w
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Potency: 0.1 %w/v
US
FDA
Route: TRANSDERMAL; Dosage form: FILM, EXTENDED RELEASE; Potency: 19 mg
US
FDA
Route: TRANSDERMAL; Dosage form: GEL; Maximum daily exposure: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 90 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 252 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION, AUGMENTED; Maximum daily exposure: 37 mg
US
FDA
Route: TOPICAL; Dosage form: SOLUTION; Maximum daily exposure: 200 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 102 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 57 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 140 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 83 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 23 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 15 mg
US
FDA
Route: BUCCAL; Dosage form: FILM; Maximum daily exposure: 100 mg
US
FDA
Route: BUCCAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 292 mg
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 670 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 176 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 114 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 45 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 54 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 67 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 594 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 19 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 88 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 630 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 364 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 32 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 150 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 480 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 103 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 40 mg
US
FDA
openFDA substance registry classifies this ingredient as polymer.
US
FDA
openFDA substance registry classifies this ingredient as mixture.